Your browser doesn't support javascript.
loading
Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites.
Tappero, Stefano; Barletta, Francesco; Piccinelli, Mattia Luca; Cano Garcia, Cristina; Incesu, Reha-Baris; Morra, Simone; Scheipner, Lukas; Baudo, Andrea; Tian, Zhe; Parodi, Stefano; Dell'Oglio, Paolo; Briganti, Alberto; de Cobelli, Ottavio; Chun, Felix K H; Graefen, Markus; Longo, Nicola; Ahyai, Sascha; Carmignani, Luca; Saad, Fred; Shariat, Shahrokh F; Suardi, Nazareno; Borghesi, Marco; Terrone, Carlo; Karakiewicz, Pierre I.
Afiliação
  • Tappero S; Division of Urology, University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Montréal, Québec, Canada; Department of Urology, IRCCS Policlinico San Martino, Genova, Italy; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy
  • Barletta F; Division of Urology, University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Montréal, Québec, Canada; Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University,
  • Piccinelli ML; Division of Urology, University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Montréal, Québec, Canada; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
  • Cano Garcia C; Division of Urology, University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Montréal, Québec, Canada; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany.
  • Incesu RB; Division of Urology, University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Montréal, Québec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Morra S; Division of Urology, University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Montréal, Québec, Canada; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", Naples, Italy.
  • Scheipner L; Division of Urology, University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Montréal, Québec, Canada; Department of Urology, Medical University of Graz, Graz, Austria.
  • Baudo A; Division of Urology, University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Montréal, Québec, Canada; Department of Urology, IRCCS Policlinico San Donato, Milan, Italy.
  • Tian Z; Division of Urology, University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Montréal, Québec, Canada.
  • Parodi S; Department of Urology, IRCCS Policlinico San Martino, Genova, Italy; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy.
  • Dell'Oglio P; Department of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Radiology, Interventional Molecular Imaging Laboratory, Leiden University Medical Center, L
  • Briganti A; Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • de Cobelli O; Vita-Salute San Raffaele University, Milan, Italy.
  • Chun FKH; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
  • Graefen M; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany.
  • Longo N; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Ahyai S; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", Naples, Italy.
  • Carmignani L; Department of Urology, Medical University of Graz, Graz, Austria.
  • Saad F; Division of Urology, University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Montréal, Québec, Canada.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY; Department of Urology, University of Texas Southwestern, Dallas, TX; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman
  • Suardi N; Department of Urology, Spedali Civili of Brescia, Brescia, Italy.
  • Borghesi M; Department of Urology, IRCCS Policlinico San Martino, Genova, Italy; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy.
  • Terrone C; Department of Urology, IRCCS Policlinico San Martino, Genova, Italy; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy.
  • Karakiewicz PI; Division of Urology, University of Montréal Health Center, Cancer Prognostics and Health Outcomes Unit, Montréal, Québec, Canada.
Urol Oncol ; 42(1): 22.e23-22.e31, 2024 01.
Article em En | MEDLINE | ID: mdl-37775340

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Carcinoma de Células Renais / Neoplasias Renais / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Carcinoma de Células Renais / Neoplasias Renais / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália